Skip to main content
Clinical Trials/NCT02203942
NCT02203942CompletedNot Applicable

Comparing NAAT Testing to Standard Methods in Diagnosis of Vaginal Infections in the General Gynecology and Vulvovaginal Referral Offices.

University of Pittsburgh1 site in 1 country300 target enrollmentStarted: July 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
300
Locations
1
Primary Endpoint
Diagnosis of Vaginal Infections

Study Overview

Brief Summary

Vaginitis is the most common condition encountered in the gynecologist's office and is most commonly caused by bacerial vaginosis (BV), vulvovaginal candidiasis (VVC) and Trichomonas vaginalis (TV). Establishing the correct etiology of symptomatic vaginitis can be challenging, and the evaluation of vaginitis by physicians is often substandard.

The investigators will determine whether NAAT testing will improve the diagnosis of vaginal infections including bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and Trichomonas vaginalis (TV).

Detailed Description

Several commercial nucleic acid amplification tests (NAAT) are available to identify causative organisms. One of these commercial tests has undergone validation published in a scientific journal, only in an STD clinic population. The primary outcome of this study is to compare NAAT diagnostic methods to traditional gold-standard tests for BV, VVC and TV in symptomatic and asymptomatic women in the general gynecology office as well as in a vulvovaginitis referral office. Addressing incorrect evaluation and diagnosis will lead to correct treatment for women suffering from vaginitis.

Study Design

Study Type
Observational
Observational Model
Case Only

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Female participants aged 18 and older
  • Based on symptoms:
  • Symptomatic patients: with symptoms of vaginitis that include abnormal discharge, malodor, itching, irritation and / or discomfort
  • Asymptomatic controls: no vulvovaginal symptoms
  • Willing to provide written informed consent for participation in this study

Exclusion Criteria

  • Use of oral antibiotics in the past 14 days
  • Use of vaginal products or lubricant, vaginal intercourse, or douching in the last 24 hour

Outcomes

Primary Outcomes

Diagnosis of Vaginal Infections

Time Frame: approximately 7 days

Compare the sensitivity and specificity of NAAT tests to Amsel criteria, Nugent score for bacterial vaginosis, yeast culture and TV culture in detecting BV, VVC, and trichomoniasis.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Harold Wiesenfeld

Associate Professor

University of Pittsburgh

Study Sites (1)

Loading locations...

Similar Trials

Comparing NAAT Testing to Standard Methods... | Clinical Trial